Moderna: Pay

No proxy on file gives executive pay for Moderna.

No pay on file. Pay comes from the Summary Compensation Table of the proxy statement.

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 3 peers with pay on file was $21.9M. The CEO of Moderna was paid $19.9M, 9% below the median.

  1. 1Incyte
  2. 2Bristol Myers Squibb
  3. 3Moderna
  4. 4Regeneron Pharmaceuticals
  5. 5Alnylam PharmaceuticalsNot disclosed
  6. 6BeOne MedicinesNot disclosed
  7. 7BioMarin PharmaceuticalNot disclosed
  8. 8BiogenNot disclosed
  9. 9Jazz PharmaceuticalsNot disclosed
  10. 10MerckNot disclosed
  11. 11Neurocrine BiosciencesNot disclosed
  12. 12Sarepta TherapeuticsNot disclosed
  13. 13Vertex PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.